Atlas Trials

A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis

Clinical trial NCT04121468 · RECRUITING

Trial details

NCT number
NCT04121468
Sponsor
The Hospital for Sick Children
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis (MS)
Start date
2020-02-24
Primary completion
2027-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.